跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68,651 条关于
“KLK2-targeted T-cell engager”
全部
68,651
临床试验
44,716
药物
6,477
机构
253
资讯
17,205
去年
Juri Biosciences Secures Global Rights to KLK2-Targeted T-Cell Engager for Metastatic Prostate Cancer in $210M Deal
去年
STEAP1-Targeted T-Cell Engager Xaluritamig Shows Promise in Advanced Prostate Cancer
去年
Cullinan Therapeutics Licenses BCMA-Targeted Bispecific T Cell Engager for Autoimmune Disease Development
去年
Zymeworks Discontinues ZW171 Mesothelin-Targeted T Cell Engager After Phase 1 Safety Concerns
9个月前
Novel mRNA-LNP Platform Delivers Liver-Targeted T Cell Engager for Hepatocellular Carcinoma Treatment
7个月前
NextPoint Therapeutics Receives FDA Clearance for First-in-Class B7-H7-Targeted T Cell Engager NPX372
3个月前
Author Correction Issued for MAGE-A4/MAGE-A8-Targeted TCR-Based Bispecific T Cell Engager Study
10个月前
IN8bio's Novel Gamma-Delta T Cell Engager Shows Promise for Autoimmune Disease Treatment
5个月前
Abogen's mRNA-Encoded T-Cell Engager ABO2203 Shows Promise in B-Cell Lymphoma with Superior Safety Profile
7个月前
Florida Cancer Specialists Launches Phase 3 Trial of Pasritamig Bispecific T-Cell Engager for Castration-Resistant Prostate Cancer
第 1 页，共 1721 页
上一页
下一页
